Dava Cleveland, DO
Family Medicine · Jackson, MSNPI 1295842169
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $99,317 of the $99,921 with a category attached, or 99.4%. CSL Behring accounts for 88.0% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2021 at $50,431 and has fallen 99.7% since, to $140 in 2024. Among family medicine clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 120 payments — averaging $832.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$88K
- CSL Plasma Inc.$12K
- Boehringer Ingelheim$149
- Pfizer$86
- Novartis$35
- Novo Nordisk$19
What the payments were for
- Royalty or licence$3000%
- Consulting fees$99,31799%
- Food & beverage$3040%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 91 | $87,932 |
| CSL Plasma Inc. | 19 | $11,700 |
| Boehringer Ingelheim | 5 | $149 |
| Pfizer | 2 | $86 |
| Novartis | 2 | $35 |
| Novo Nordisk | 1 | $19 |
How this compares
$99,921 in reported general payments places this provider in the 95th percentile of 971 family medicine providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 23 | $16,560 |
| OzempicSemaglutide | 13 | $13,928 |
| LinzessLinaclotide | 13 | $7,280 |
| Atorvastatin Calcium | 88 | $1,003 |
| Rosuvastatin Calcium | 38 | $691 |
| Pantoprazole Sodium | 36 | $603 |
| Gabapentin | 26 | $495 |
| Losartan Potassium | 42 | $388 |
| Metoprolol Succinate | 27 | $375 |
| Potassium Chloride | 18 | $280 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $279 |
| Fluticasone Propionate | 19 | $232 |
| Fluoxetine Hcl | 19 | $224 |
| Omeprazole | 29 | $215 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $209 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $86 | $16,56023 claims |
| Novo NordiskOzempic | $19 | $13,92813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 971 family medicine providers in Mississippi.
Other family medicine in Jackson
- Andrea PhillipsJackson$96K
- Massie HeadleyJackson$10K
- Russell CarlisleWesson$1.6M
- Keith StokesLexington$654K
- Walter CarnahanSouthaven$146K
- Karen WhitneyWhitfield$117K
- Kristi TrimmRidgeland$34K
- Tana CooperBiloxi$25K
- Delora DenneyPicayune$24K
- Randall HulingOlive Branch$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.